Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors [Phase 1, Phase 2]
This update reports the termination of a Phase 1/2 trial of AMG 655 in combination with AMG 479 for advanced, refractory solid tumors, with …
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions [NA]
A clinical trial evaluating 22G Adapt Needle Biopsy versus standard fine-needle aspiration for endoscopic ultrasound-guided sampling of soli…
-
CLINICAL_TRIALS other · 2024-08-20Clinical Trial Update: A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer [Phase 1, Phase 2]
This entry describes a Phase I/II clinical trial of UCB4594 for multiple advanced solid tumors, including head and neck squamous cell carcin…
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial studying Fluzoparib in combination with mFOLFIRINOX in advanced pancreatic cancer has completed Phase 1/2 enrollment.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Exercise and Nutrition to Improve Pancreatic Cancer Outcomes [NA]
This entry reports a University of Oklahoma-sponsored clinical trial evaluating exercise and nutrition to improve outcomes for pancreatic ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) [Phase 2]
Phase 2 study MK-2140-002 evaluating Zilovertamab vedotin (VLS-101) in solid tumors including triple-negative breast cancer and non-small-ce…
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic Cancer [Phase 2]
The Phase 2 trial evaluating devimistat in combination with mFFX for second-line metastatic pancreatic cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) [Phase 2]
A Phase 2 trial (CAPE-X) evaluating CAPEcitabine as adjuvant therapy for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial evaluating GVAX pancreatic tumor cell vaccine with cyclophosphamide, SBRT, and the FOLFIRINOX regimen in patients with resecte…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer [Phase 2]
Phase 2 trial update for a vitamin C plus G-FLIP regimen (low-dose gemcitabine, 5-FU, leucovorin, irinotecan, oxaliplatin) in pancreatic can…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
A completed clinical trial update examining whether albumin levels, HALP score, and LCR value can predict survival and recurrence in pancrea…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer [EARLY_Phase 1]
Early-phase trial evaluating pharmacogenomics-guided use of supportive care medications in patients with advanced cancers; the study has com…
-
CLINICAL_TRIALS withdrawal · 2024-08-13Clinical Trial Update: Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating TNG348 alone and in combination with a PARP inhibitor for BRCA1/2-mutant or HRD-positive solid tumors has been …
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 1]
Phase 1 study MT-601 in locally advanced unresectable or metastatic pancreatic cancer; study status is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling [NA]
A completed clinical trial evaluating genetic counseling augmented with an educational video or pamphlet versus traditional counseling metho…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]
Exploratory Phase 1/2 trial evaluating HRS-4642 in combination with Adebelimab for advanced pancreatic cancer; study status: recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study of CAR-T cells targeting the carcinoembryonic antigen (CEA) for CEA-positive…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial from Fudan University is evaluating adebrelimab in combination with NALIRIFOX for locally advanced pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Clinical trial update for the RADIANT study evaluating radiotherapy assessments during intervention and treatment; the trial covers multiple…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice [NA]
This clinical trial registry entry describes a new preoperative drainage strategy for resectable pancreatic head cancer with severe obstruct…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer [Phase 1, Phase 2]
This clinical trial update reports the termination of the Phase 1/2 study QUILT-3.040 evaluating ETBX-011 vaccine in combination with ALT-80…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Clinical Study Evaluating the Effect of Losartan [NA]
A clinical trial is evaluating losartan for pancreatic cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Food Reward in Cachexia Induced by Acute or Chronic Disease
The clinical trial evaluating food reward as a treatment for cachexia across acute or chronic diseases has been terminated; the conditions i…
-
CLINICAL_TRIALS trial_result · 2024-08-05Clinical Trial Update: Home-based Prehabilitation in Pancreatic Resection [NA]
A completed clinical trial (NCT05496777) evaluating home-based prehabilitation, including preoperative physical exercise training and aerobi…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial comparing orathecin plus gemcitabine versus placebo plus gemcitabine in chemonaive non-resectable pancreatic cancer …